MSD Announces US Government Supply Agreement for Molnupiravir, an Oral Antiviral Investigational…
MSD Announces US Government Supply Agreement for Molnupiravir, an oral antiviral investigational candidate for the treatment of mild to moderate COVID-19 PRNewswire